Integra Lifesciences Holdings Corp (IART)
24.14
+4.86
(+25.21%)
USD |
NASDAQ |
Nov 04, 16:00
24.16
+0.02
(+0.08%)
After-Hours: 20:00
Integra Lifesciences Holdings Revenue (Quarterly): 418.18M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 418.18M |
| March 31, 2024 | 368.87M |
| December 31, 2023 | 397.04M |
| September 30, 2023 | 382.42M |
| June 30, 2023 | 381.27M |
| March 31, 2023 | 380.85M |
| December 31, 2022 | 398.02M |
| September 30, 2022 | 385.19M |
| June 30, 2022 | 397.82M |
| March 31, 2022 | 376.64M |
| December 31, 2021 | 405.52M |
| September 30, 2021 | 386.86M |
| June 30, 2021 | 389.99M |
| March 31, 2021 | 360.07M |
| December 31, 2020 | 388.65M |
| September 30, 2020 | 370.23M |
| June 30, 2020 | 258.66M |
| March 31, 2020 | 354.32M |
| December 31, 2019 | 395.13M |
| September 30, 2019 | 379.10M |
| June 30, 2019 | 383.64M |
| March 31, 2019 | 359.69M |
| December 31, 2018 | 383.32M |
| September 30, 2018 | 365.85M |
| June 30, 2018 | 366.19M |
| Date | Value |
|---|---|
| March 31, 2018 | 357.08M |
| December 31, 2017 | 368.60M |
| September 30, 2017 | 278.83M |
| June 30, 2017 | 282.16M |
| March 31, 2017 | 258.64M |
| December 31, 2016 | 255.66M |
| September 30, 2016 | 250.33M |
| June 30, 2016 | 249.31M |
| March 31, 2016 | 236.77M |
| December 31, 2015 | 241.16M |
| September 30, 2015 | 226.37M |
| June 30, 2015 | 212.67M |
| March 31, 2015 | 202.53M |
| December 31, 2014 | 219.07M |
| September 30, 2014 | 197.52M |
| June 30, 2014 | 231.35M |
| March 31, 2014 | 215.06M |
| December 31, 2013 | 81.39M |
| September 30, 2013 | 213.25M |
| June 30, 2013 | 205.55M |
| March 31, 2013 | 196.65M |
| December 31, 2012 | 214.43M |
| September 30, 2012 | 210.08M |
| June 30, 2012 | 210.17M |
| March 31, 2012 | 196.18M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
258.66M
Minimum
Jun 2020
418.18M
Maximum
Jun 2024
378.72M
Average
385.19M
Median
Sep 2022
Revenue (Quarterly) Benchmarks
| Abbott Laboratories | 10.64B |
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 6.029M |
| Xtant Medical Holdings Inc | 29.94M |
| Catheter Precision Inc | 0.093M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.40M |
| Total Expenses (Quarterly) | 421.20M |
| EPS Diluted (Quarterly) | -0.16 |
| Enterprise Value | 3.024B |
| Gross Profit Margin (Quarterly) | 54.02% |
| Profit Margin (Quarterly) | -2.97% |
| Earnings Yield | 1.20% |
| Operating Earnings Yield | 3.37% |
| Normalized Earnings Yield | 1.201 |